Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Coscarella

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 27, 2024
Long-term therapeutic response to dupilumab in patients affected by prurigo nodularis: A real-world retrospective studyAndrea Chiricozzi, Niccolò Gori, Elena Ippoliti, et al.
Italian Journal of Dermatology and Venereology|May 8, 2023
The role of cutaneous human-papillomavirus (HPV) infection in in situ squamous cell carcinoma: a pilot studyClaudio Conforti, Serena Bonin, Giulia Coscarella, et al.
Journal of the American Academy of Dermatology|May 14, 2025
Diagnostic unmet needs in brachioradial pruritusGiulia Coscarella, Yael Rosen, Nathanael Singer, et al.
Frontiers in Medicine|January 26, 2024
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilledGiulia Coscarella, Gennaro Marco Falco, Gerardo Palmisano, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 29, 2024
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case seriesNiccolò Gori, Elena Ippoliti, Silvia Mariel Ferrucci, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 11, 2024
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort studyAndrea Chiricozzi, Giulia Coscarella, Luis Puig, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 27, 2024
Long-term therapeutic response to dupilumab in patients affected by prurigo nodularis: A real-world retrospective studyAndrea Chiricozzi, Niccolò Gori, Elena Ippoliti, et al.
Italian Journal of Dermatology and Venereology|May 8, 2023
The role of cutaneous human-papillomavirus (HPV) infection in in situ squamous cell carcinoma: a pilot studyClaudio Conforti, Serena Bonin, Giulia Coscarella, et al.
Journal of the American Academy of Dermatology|May 14, 2025
Diagnostic unmet needs in brachioradial pruritusGiulia Coscarella, Yael Rosen, Nathanael Singer, et al.
Frontiers in Medicine|January 26, 2024
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilledGiulia Coscarella, Gennaro Marco Falco, Gerardo Palmisano, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 29, 2024
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case seriesNiccolò Gori, Elena Ippoliti, Silvia Mariel Ferrucci, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 11, 2024
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort studyAndrea Chiricozzi, Giulia Coscarella, Luis Puig, et al.
Pageof 3